Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 11, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

October 20, 2016

Conditions
TransplantationSystemic Lupus ErythematosusSystemic Immune Disease
Interventions
BIOLOGICAL

HPV prophylactic vaccine Gardasil

3 injections: at Inclusion visit then 2 and 6 months after.

Trial Locations (9)

31059

CHU de Toulouse, Hôpital des Enfants, Toulouse

33076

CHU de Bordeaux, Hôpital Pellegrin-Enfants, Bordeaux

34295

CHU de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier

44093

CHU de Nantes, Hôpital Mère-Enfants, Nantes

59037

CHU de Lille, Hôpital Jeanne de Flandres, Lille

69677

HCLyon, Hôpital Femme-mère-enfant, Bron

75019

AP-HP, Hôpital Robert Debré, Paris

75571

AP-HP, Hôpital Armand Trousseau, Paris

75743

AP-HP, Hôpital Necker-Enfants, Paris

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT01687192 - Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. | Biotech Hunter | Biotech Hunter